Close

Horizon Therapeutics seen worth up to $140/share in takeover Nov 30, 2022 08:12AM
Horizon Therapeutics (HZNP) PT Lowered to $140 at Cowen Aug 3, 2022 10:51AM
Matter of When, Not If Horizon Therapeutics (HZNP) Tepezza Will Be Adopted - Cowen Jul 12, 2022 06:51AM
Horizon Therapeutics plc to Present at the Cowen and Company 42nd Annual Health Care Conference Feb 21, 2022 04:05PM
Horizon Therapeutics (HZNP) PT Raised to $155 at Cowen Nov 3, 2021 10:13AM
View Older Stories

Aug 4, 2021 10:49AM Horizon Therapeutics (HZNP) PT Raised to $140 at Cowen, Following Earnings
Jul 21, 2021 08:49AM Cowen Pounds the Table on Horizon Therapeutics (HZNP), Says Add to Positions Before Earnings
May 5, 2021 11:30AM Horizon Therapeutics (HZNP) Tepezza is Now Underway, Add Stock - Cowen
Feb 26, 2021 04:05PM Horizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care Conference
Feb 24, 2021 09:51AM Horizon Therapeutics (HZNP) PT Raised to $120 at Cowen
Jan 7, 2021 07:19AM Cowen's Tepezza Survey Confirms Investor Expectations Remain Low, Horizon Therapeutics (HZNP) PT Reiterated at $115
Nov 2, 2020 10:14AM Horizon Therapeutics (HZNP) PT Raised to $115 at Cowen Following Q3 Results
Aug 11, 2020 05:00PM Horizon Therapeutics plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares
Aug 7, 2020 06:35AM Horizon Therapeutics (HZNP) Prices 11.8M Share Offering at $71
Aug 6, 2020 11:20PM Horizon Therapeutics plc Announces Pricing of Public Offering of Ordinary Shares
Aug 5, 2020 04:13PM Horizon Therapeutics (HZNP) Announces Proposed $700M Public Offering of Ordinary Shares
Aug 5, 2020 04:01PM Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares
Aug 5, 2020 10:31AM Horizon Therapeutics (HZNP) PT Raised to $100 at Cowen
May 6, 2020 11:53AM Horizon Therapeutics (HZNP) PT Raised to $55 at Cowen
Feb 26, 2020 10:34AM Horizon Therapeutics (HZNP) PT Raised to $50 at Cowen
Feb 18, 2020 08:30AM Horizon Therapeutics plc to Present at the Cowen and Company 40th Annual Health Care Conference
Dec 16, 2019 07:07AM Horizon Pharma (HZNP) PT Raised to $41 at Cowen
Dec 11, 2019 10:00AM Horizon Pharma (HZNP) Volatile Following FDA Briefing Docs for Teprotumumab
Nov 6, 2019 10:05AM Horizon Pharma (HZNP) PT Raised to $39 at Cowen
Aug 7, 2019 11:42AM Horizon Pharma (HZNP) PT Raised to $35 at Cowen
Mar 11, 2019 04:30PM Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 7, 2019 05:50AM Horizon Pharma (HZNP) Prices 12.245M Share Common Offering at $24.50/Sh
Mar 6, 2019 10:00PM Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares
Mar 6, 2019 09:30AM Pre-Open Stock Movers 03/06: (ANF) (ZAYO) (AMBA) Higher; (VLRX) (CLDX) (PRMW) Lower (more...)
Mar 4, 2019 05:31PM Horizon Pharma (HZNP) to Offer $300M in Common Stock
Mar 4, 2019 04:10PM Horizon Pharma plc Announces Proposed Public Offering of Ordinary Shares
Feb 28, 2019 10:49AM Horizon Pharma (HZNP) PT Raised to $33 at Cowen
Feb 25, 2019 08:00AM Horizon Pharma plc to Participate in Cowen and Company 39th Annual Health Care Conference
Aug 8, 2018 10:02AM Horizon Pharma (HZNP) PT Raised to $25 at Cowen
May 9, 2018 11:22AM Horizon Pharma (HZNP) Primary Care Should be Viewed as Strategic/Monetizeable, Not Core - Cowen
Feb 26, 2018 07:00AM Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference
Jan 2, 2018 05:35PM Drugmakers raise 2018 U.S. prices, stick to self-imposed limits
May 8, 2017 11:45AM Horizon Pharma (HZNP) PT Lowered to $20 at Cowen; Valuation Suggests Investors Step in Here
Feb 14, 2017 08:00AM Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care Conference
Sep 12, 2016 09:41AM Notable Mergers and Acquisitions 9/12: (AGU)/(POT) (HPQ) (HZNP)/(RPTP) (OTEX)
Sep 12, 2016 07:01AM Horizon Pharma plc (HZNP) to Acquire Raptor Pharmaceutical (RPTP) for $800M
Sep 12, 2016 07:00AM Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business
Mar 1, 2016 07:00AM Horizon Pharma plc to Participate in Cowen and Company 36th Annual Health Care Conference
Nov 23, 2015 10:37AM Notable Analyst Rating Changes 11/23: (CMG) (JRVR) (PBF) Upgraded; (TXTR) (CTCT) (CAVM) Downgraded
Apr 21, 2015 09:48AM Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares
Apr 16, 2015 08:23AM Horizon Pharma (HZNP) Prices Larger 15.35M Common Offering at $28.25/Share
Apr 15, 2015 06:47PM Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares
Apr 13, 2015 04:02PM Horizon Pharma (HZNP) to Offer 12M Common Shares
Apr 13, 2015 04:01PM Horizon Pharma plc Announces Proposed Public Offering of Ordinary Shares
Mar 30, 2015 09:45AM Notable Mergers and Acquisitions 3/30: (CTRX)/(UNH) (TEVA)/(ASPX) (HZNP)/(HPTX) (ICEL)
Mar 30, 2015 06:10AM Horizon Pharma (HZNP) to Acquire Hyperion Therapeutics (HPTX) in $1.1B Deal
Mar 30, 2015 06:00AM Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
Mar 13, 2015 04:05PM Horizon Pharma plc Closes Offering of $400 Million of 2.50% Exchangeable Senior Notes, Including Exercise in Full of Option to Purchase Additional Notes
Mar 6, 2015 06:45AM Horizon Pharma plc Prices Offering of $350 Million of 2.50% Exchangeable Senior Notes
Nov 14, 2014 08:03AM Horizon Pharma (HZNP) Prices 11.66M Common Secondary at $12.05/Share
View Older Stories